We found that decreasing the expression level of GNG5 in glioma cells could significantly affect the expression of VCAM1, ICAM1, CDH2, and SDC2, which are key molecules of cell adhesion molecules (Fig. 5b, c). This evidence concerns the gene ICAM1 and central nervous system cancer.